[Federal Register Volume 61, Number 221 (Thursday, November 14, 1996)] [Notices] [Pages 58423-58424] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-29117] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 6, 1996, Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts [[Page 58424]] 01810, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Amphetamine (1100).......................... II Methamphetamine (1105)...................... II Pentobarbital (2270)........................ II Secobarbital (2315)......................... II Phencyclidine (7471)........................ II Phenylacetone (8501)........................ II Cocaine (9041).............................. II Codeine (9050).............................. II Oxycodone (9143)............................ II Benzoylecgonine (9180)...................... II Methadone (9250)............................ II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Morphine (9300)............................. II Fentanyl (9801)............................. II ------------------------------------------------------------------------ The firm plans to manufacture small quantities of the above listed controlled substances for isotope labeled standards for drug analysis. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than January 13, 1997. Dated: October 21, 1996. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 96-29117 Filed 11-13-96; 8:45 am] BILLING CODE 4410-09-M